Pathogenetics of the human SLC26 transporters

被引:67
作者
Dawson, PA [1 ]
Markovich, D [1 ]
机构
[1] Univ Queensland, Dept Physiol & Pharmacol, Sch Biomed Sci, St Lucia, Qld 4072, Australia
关键词
sulfate; transporter; chondrodysplasia; diarrhea; deafness;
D O I
10.2174/0929867053363144
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Over the past decade, 11 human genes belonging to the solute linked carrier (SLC) 26 family of transporters, have been identified. The SLC26 proteins, which include SAT-1, DTDST, DR-A/CLD, pendrin, prestin, PAT-1/CFEX and Tat-1, are structurally related and have been shown to transport one or more of the following substrates: sulfate, chloride, bicarbonate, iodide, oxalate, formate, hydroxyl or fructose. Special interest has focused on four members of the SLC26 family that are associated with distinct recessive diseases: (i) Mutations in SLC26A2 lead to four different chondrodysplasias (diastrophic dysplasia, atelosteogenesis type 11, achondrogenesis type 113 and multiple epiphyseal dysplasia); (ii) SLC26A3 is associated with congenital chloride diarrhea; (iii) SLC26A4 is associated with Pendred syndrome and non-syndromic deafness, DFNB4; and (iv) SLC26A5 is defective in non-syndromic hearing impairment. This review article summarizes current information on the pathophysiological consequences of mutations in the human SLC26A2 to A5 genes.
引用
收藏
页码:385 / 396
页数:12
相关论文
共 103 条
[1]   Deafness heterogeneity in a Druze isolate from the Middle East: novel OTOF and PDS mutations, low prevalence of GJB2 35delG mutation and indication for a new DFNB locus [J].
Adato, A ;
Raskin, L ;
Petit, C ;
Bonne-Tamir, B .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2000, 8 (06) :437-442
[2]   Proton-pump inhibition of gastric chloride secretion in congenital chloridorrhea [J].
Aichbichler, BW ;
Zerr, CH ;
SantaAna, CA ;
Porter, JL ;
Fordtran, JS .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (02) :106-109
[3]   Recessive multiple epiphyseal dysplasia (rMED):: phenotype delineation in eighteen homozygotes for DTDST mutation R279W [J].
Ballhausen, D ;
Bonafé, L ;
Terhal, P ;
Unger, SL ;
Bellus, G ;
Classen, M ;
Hamel, BC ;
Spranger, J ;
Zabel, B ;
Cohn, DH ;
Cole, WG ;
Hecht, JT ;
Superti-Furga, A .
JOURNAL OF MEDICAL GENETICS, 2003, 40 (01) :65-71
[4]   Expression of Na+/I- symporter and pendred syndrome genes in trophoblast cells [J].
Bidart, JM ;
Lacroix, L ;
Evain-Brion, D ;
Caillou, B ;
Lazar, V ;
Frydman, R ;
Bellet, D ;
Filetti, S ;
Schlumberger, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) :4367-4372
[5]   A novel mutation in the pendrin gene associated with Pendred's syndrome [J].
Bogazzi, F ;
Raggi, F ;
Ultimieri, F ;
Campomori, A ;
Cosci, C ;
Berrettini, S ;
Neri, E ;
La Rocca, R ;
Ronca, G ;
Martino, E ;
Bartalena, L .
CLINICAL ENDOCRINOLOGY, 2000, 52 (03) :279-285
[6]   Mutations in the PDS gene in German families with Pendred's syndrome:: V138F is a founder mutation [J].
Borck, G ;
Roth, C ;
Martiné, U ;
Wildhardt, G ;
Pohlenz, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06) :2916-2921
[7]  
Byeon MK, 1996, ONCOGENE, V12, P387
[8]  
Cai GM, 1998, AM J MED GENET, V78, P58, DOI 10.1002/(SICI)1096-8628(19980616)78:1<58::AID-AJMG12>3.3.CO
[9]  
2-F
[10]   Pendred syndrome, DFNB4, and PDS/SCL26A4 identification of eight novel mutations and possible genotype-phenotype correlations [J].
Campbell, C ;
Cucci, RA ;
Prasad, S ;
Green, GE ;
Edeal, JB ;
Galer, CE ;
Karniski, LP ;
Sheffield, VC ;
Smith, RJH .
HUMAN MUTATION, 2001, 17 (05) :403-411